Page last updated: 2024-08-22

trolamine salicylate and Osteoporosis, Postmenopausal

trolamine salicylate has been researched along with Osteoporosis, Postmenopausal in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (18.18)18.2507
2000's6 (54.55)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Graves, DT; Li, S; Pacios, S; Wang, Y; Xiao, W1
Uğurlar, M1
Alcaraz, MJ; Caeiro, JR; Ferrándiz, ML; Guede, D; Ibáñez, L; Maicas, N; Motterlini, R1
Gerster, JH1
Brixen, KT; Frederiksen, L; Junker, P1
Carlsten, H; Islander, U; Jochems, C; Kallkopf, A; Lagerquist, M; Ohlsson, C1
Gwynne Jones, DP; Highton, J; Savage, RL1
Barrett-Connor, E; Kritz-Silverstein, D1
Delmas, PD; Uebelhart, D1
Kong, YY; Penninger, JM1
Arendt, EA1

Reviews

4 review(s) available for trolamine salicylate and Osteoporosis, Postmenopausal

ArticleYear
Bone Remodeling Under Pathological Conditions.
    Frontiers of oral biology, 2016, Volume: 18

    Topics: Arthritis; Biomechanical Phenomena; Bone Diseases; Bone Remodeling; Bone Resorption; Humans; Inflammation Mediators; Osteogenesis; Osteoporosis, Postmenopausal; Periodontal Diseases; Weightlessness

2016
[Assay of cross-linking molecules of collagen (pyridinolines) in the study of the degradation of bone tissue and articular cartilage].
    Pathologie-biologie, 1993, Volume: 41, Issue:10

    Topics: Adolescent; Adult; Amino Acids; Arthritis; Bone and Bones; Bone Resorption; Cartilage, Articular; Child; Chromatography, High Pressure Liquid; Collagen; Female; Humans; Male; Middle Aged; Osteoporosis, Postmenopausal

1993
Molecular control of bone remodeling and osteoporosis.
    Experimental gerontology, 2000, Volume: 35, Issue:8

    Topics: Animals; Arthritis; Bone Remodeling; Carrier Proteins; Dendritic Cells; Female; Glycoproteins; Humans; Lymph Nodes; Membrane Glycoproteins; Mice; Osteoporosis; Osteoporosis, Postmenopausal; Osteoprotegerin; RANK Ligand; Rats; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; T-Lymphocytes

2000
Gender differences in musculoskeletal health.
    The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia, 2000, Volume: 3, Issue:7

    Topics: Arthritis; Athletic Injuries; Female; Gonadal Steroid Hormones; Humans; Male; Musculoskeletal Diseases; Osteoporosis, Postmenopausal; Risk Factors; Sex Characteristics

2000

Other Studies

7 other study(ies) available for trolamine salicylate and Osteoporosis, Postmenopausal

ArticleYear
Alendronate- and risedronate-induced acute polyarthritis.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2016, Volume: 27, Issue:11

    Topics: Alendronate; Arthritis; Bone Density Conservation Agents; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Risedronic Acid

2016
Downregulation of the inflammatory response by CORM-3 results in protective effects in a model of postmenopausal arthritis.
    Calcified tissue international, 2012, Volume: 91, Issue:1

    Topics: Alendronate; Animals; Anti-Inflammatory Agents; Arthritis; Biomarkers; Disease Models, Animal; Down-Regulation; Female; Humans; Inflammation; Mice; Mice, Inbred DBA; Organometallic Compounds; Osteoporosis, Postmenopausal

2012
Acute polyarthritis related to once-weekly alendronate in a woman with osteoporosis.
    The Journal of rheumatology, 2004, Volume: 31, Issue:4

    Topics: Acute Disease; Alendronate; Arthralgia; Arthritis; Drug Administration Schedule; Female; Humans; Joints; Middle Aged; Muscular Diseases; Osteoporosis, Postmenopausal; Pain

2004
[Persistent polyarticular synovitis after treatment with alendronate].
    Ugeskrift for laeger, 2007, Apr-23, Volume: 169, Issue:17

    Topics: Alendronate; Arthritis; Bone Density Conservation Agents; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Synovitis

2007
Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis.
    Arthritis and rheumatism, 2007, Volume: 56, Issue:10

    Topics: Animals; Arthritis; Arthritis, Experimental; Bone Density; Cytokines; Female; Humans; Mice; Osteoporosis, Postmenopausal; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; RANK Ligand; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Estrogen Receptor Modulators; Thiophenes; Treatment Outcome; Tumor Necrosis Factor-alpha

2007
Alendronate-induced synovitis.
    The Journal of rheumatology, 2008, Volume: 35, Issue:3

    Topics: Aged; Alendronate; Arthritis; Bone Density Conservation Agents; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Registries; Synovitis

2008
Grip strength and bone mineral density in older women.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1994, Volume: 9, Issue:1

    Topics: Absorptiometry, Photon; Aged; Arthritis; Benzothiadiazines; Body Mass Index; Bone Density; Diuretics; Estrogens; Exercise; Female; Hip; Humans; Muscles; Osteoporosis, Postmenopausal; Radius; Regression Analysis; Risk Factors; Smoking; Sodium Chloride Symporter Inhibitors; Spine; Wrist

1994